logo
An integrated view on promoter as well as business to help in assessing lending risk to MSMEs

An integrated view on promoter as well as business to help in assessing lending risk to MSMEs

Business Mayor18-05-2025
Credit bureau CRIF has started offering such services.
'Many MSMEs find it challenging to access formal credit due to factors such as informal nature of business and lack of collateral,' said Sachin Seth, regional MD-India and South Asia at CRIF, a global fintech company that specialises in credit bureau and business information. said. 'On the other hand, lenders find it difficult to assess credit risk of these enterprises as this demands a comprehensive assessment of the financial health of the business and the credit risk profile of the business owners.'
Credit gap—the difference between the demand for debt and supply of debt—for MSMEs is estimated at Rs 30 lakh crore, according to a report released by Sidbi last week.
'To bridge this gap, CRIF offers a unique solution by integrating the consumer and commercial credit information coupled with CRIF's credit score and CIBR (CRIF India Business Rank). When risk assessment of self-employed or business is involved, lenders can leverage CRIF's credit score combined with CIBR for superior risk separation,' Seth said.
Business loans are a part of CRIF's commercial repository. CRIF uses this information to compute CIBR, which reflects the credit risk associated with the entity/business, while loans taken by individuals in their personal capacity are a part of its consumer repository and are used to compute CRIF credit score, which reflects the credit risk associated with the individual.CRIF is reckoned to be the only credit bureau to offer this integrated information to the lender.'While all credit bureaus have both consumer and commercial repositories, CRIF is the only credit bureau which provides integrated information along with a credit score and CIBR,' a CRIF executive said, adding that over 100 lenders have used this facility.
The government is also doing its bit to help improve credit access for MSMEs. It has launched a new Credit Assessment Model for micro and small enterprises based on scoring their digital footprints, which was announced in the July 2024 budget.
This credit assessment model leverages the digitally fetched and verifiable data available in the ecosystem and devise automated journeys for MSME loan appraisal using objective decisioning for all loan applications and model-based limit assessment for both existing-to-bank (ETB) and new-to-bank (NTB) MSME borrowers.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy' Rating With $342 PT
Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy' Rating With $342 PT

Yahoo

time3 days ago

  • Yahoo

Elevance Health, Inc. (ELV) Reports Q2 2025 Results; Mizuho Maintains ‘Buy' Rating With $342 PT

With a low price-to-earnings multiple and a significant presence in Seth Klarman's investment portfolio, Elevance Health, Inc. (NYSE:ELV) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman. Scientist in a lab working on a research project, focusing on biotechnology and healthcare advancements. On July 17, 2025, Elevance Health, Inc. (NYSE:ELV) released its Q2 2025 results. The company posted adjusted EPS of $8.84, slightly missing expectations of $8.91. Increased medical cost trends in ACA, along with slower Medicaid rate recovery softening margins. Yet, the higher premium yields and acquisitions resulted in a $49.4 billion revenue, an increase of 14% YoY. Meanwhile, the company's operating cash flow reached $2.1 billion. Declines in Medicaid and ACA enrollment resulted in a decrease in the Membership segment, taking it to 45.6 million. Looking ahead, Elevance Health, Inc. (NYSE:ELV) reduced its full-year EPS guidance to $30, driven by cost pressures. However, it reaffirmed its strategies to stabilize margins with disciplined pricing, AI-enabled care management, and Carelon's expanding value-based and pharmacy services. Despite the reduction in 2025 guidance, Mizuho maintained its 'Buy' rating on Elevance Health, Inc. (NYSE:ELV) with a $342 price target. The analyst's optimism is driven by the company's growth potential in Carelon and strong execution in Medicare Advantage. Elevance Health, Inc. (NYSE:ELV) is a health insurance provider, offering integrated medical, pharmacy, and care delivery solutions. It is included in our list of cheap value stocks to buy. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Eagle Materials Inc. (EXP) Declares Quarterly Cash Dividend; Loop Capital Raises PT to $245
Eagle Materials Inc. (EXP) Declares Quarterly Cash Dividend; Loop Capital Raises PT to $245

Yahoo

time3 days ago

  • Yahoo

Eagle Materials Inc. (EXP) Declares Quarterly Cash Dividend; Loop Capital Raises PT to $245

Eagle Materials Inc. (NYSE:EXP) is included in our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman. A construction site with workers in hard hats building a new commercial property, financing provided by the regional bank. Following strong recent operational performance, Loop Capital increased its price target on Eagle Materials Inc. (NYSE:EXP) from $230 to $245 on July 30, 2025, maintaining a 'Hold' rating. The increased target reflects the company's stable wallboard pricing, above-industry segment volumes, and improved investor sentiment surrounding a potential building products trough. However, the analyst believes that a stronger catalyst beyond a cyclical recovery is required to upgrade its rating on the company. Meanwhile, on August 6, 2025, Eagle Materials Inc. (NYSE:EXP)'s Board declared a quarterly cash dividend of $0.25 per share, which is payable on October 16 to shareholders of record as of September 15. Eagle Materials Inc. (NYSE:EXP), based in the U.S., provides building materials, such as cement, concrete, and gypsum wallboard products. It is included in our list of cheap value stocks to buy. While we acknowledge the potential of EXP as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Best Oil Refinery Stocks to Buy Right Now and 7 Best Potash Stocks to Buy According to Analysts. Disclosure: None. Sign in to access your portfolio

CRH plc (CRH) Reports Q2 2025 Results; RBC Capital Raises PT and Maintains ‘Outperform' Rating
CRH plc (CRH) Reports Q2 2025 Results; RBC Capital Raises PT and Maintains ‘Outperform' Rating

Yahoo

time3 days ago

  • Yahoo

CRH plc (CRH) Reports Q2 2025 Results; RBC Capital Raises PT and Maintains ‘Outperform' Rating

With a low price-to-earnings multiple and a significant presence in Seth Klarman's investment portfolio, CRH plc (NYSE:CRH) earns a spot on our list of the 12 Cheap Value Stocks to Buy Now According to Seth Klarman. A worker making repairs on a newer home, representing new construction as part of the company's offerings. On August 6, 2025, CRH plc (NYSE:CRH) reported its results for Q2 2025. Thanks to strategic acquisitions and pricing discipline, the company posted 6% revenue growth to $10.2 billion and a 9% increase in adjusted EBITDA to $2.5 billion. Meanwhile, net income remained stable at $1.3 billion, while EPS improved to $1.94. Performance was solid across all segments, with the International Solutions segment recording a 13% revenue growth. On a year-to-date basis, CRH plc (NYSE:CRH) finalized 13 acquisitions, including a $2.1 billion acquisition of Eco Material Technologies on July 29, strengthening its position in low-carbon cement. Furthermore, the company returned $0.8 billion to shareholders in the form of repurchases YTD, with a new $0.3 billion tranche authorized on August 5, alongside a quarterly dividend of $0.37 declared. CRH also raised its full-year guidance, thanks to solid demand in infrastructure and resilient non-residential markets. Citing the company's differentiated model and M&A-driven growth, RBC Capital raised its price target on CRH plc (NYSE:CRH) from $108 to $112 on August 8, maintaining an 'Outperform' rating. Serving the construction industry, CRH plc (NYSE:CRH) operates as a leader in building materials, supplying cement, concrete, aggregates, and related products. It is included in our list of cheap value stocks to buy. While we acknowledge the potential of CRH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best AI Stocks to Buy Under $3 and Bill Ackman Stock Portfolio: Top 10 Stock Picks. Disclosure: None. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store